<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Transtec; Buprenorphine: pain" /><meta name="IX" content="Transtec; Buprenorphine: pain" /><title>Transtec®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="106521.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="106521.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=106521.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2055.htm">4 Central nervous system</a> &gt; <a href="3456.htm">4.7 Analgesics</a> &gt; <a href="3491.htm">4.7.2 Opioid analgesics</a> &gt; <a href="3512.htm">BUPRENORPHINE</a> &gt; <a href="130012.htm">Patches</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="3491.htm" title="Previous: 4.7.2 Opioid analgesics">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="3514.htm" title="Next: CODEINE PHOSPHATE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a387004.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buprenorphine, Buprenorphine Hydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Analgesics and Antipyretics 28:08 &gt; Opiate Partial Agonists 28:08.12</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/19995-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Buprenorphine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: B &gt; Interactions of Buprenorphine</p></div></li></ul><ul><li><h3>British National Formulary (11)</h3></li><li><a href="29424.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Controlled Drugs and drug dependence</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing</p></div></li><li><a href="29450.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pain</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing &gt; Prescribing in palliative care</p></div></li><li><a href="3491.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">4.7.2 Opioid analgesics</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.7 Analgesics</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22buprenorphine%22%22buprenorphine%22%22buprenorphine%22%22buprenorphine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (11)</a></li></ul><ul><li><h3>BNF for Children (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/3491.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">4.7.2 Opioid analgesics</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.7 Analgesics</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/3512.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">BUPRENORPHINE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.7 Analgesics &gt; 4.7.2 Opioid analgesics</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/3513.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Temgesic®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.7 Analgesics &gt; 4.7.2 Opioid analgesics &gt; BUPRENORPHINE</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/c-d1e168521.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buprenorphine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; B</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a589005.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buprenorphine Hydrochloride</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; B</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0002s0184.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buprenorphine</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; B</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/b07-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buprenorphine</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; B</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-19995-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buprenorphine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Analgesics Anti-inflammatory Drugs and Antipyretics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/01497.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buprenorphine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; B &gt; BU</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E8E3E0R0D42.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Buprenorphine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; B</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_3512">BUPRENORPHINE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i87.htm" title="Go to appendix 1">Buprenorphine</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">see under Dose and under Patches; opioid dependence (<a title="BNF:monograph-family: Opioid substitution therapy" href="213722.htm#_213722">section 4.10.3</a>)</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF"><span id="_200524">see <a title="target-block: OPIOID ANALGESIC CAUTIONS" href="3491.htm#_200091">notes above</a>; also impaired consciousness; effects only partially
reversed by naloxone; monitor liver function</span></p><div class="cAV"><h3>Fever or external heat</h3> <p class="cAX">Monitor patients
using patches for increased side-effects if fever present (increased
absorption possible); avoid exposing application
site to external heat (may also increase absorption)</p></div></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF"><span id="_200525">see <a title="target-block: OPIOID ANALGESIC CONTRA-INDICATIONS" href="3491.htm#_200093">notes above</a></span></p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">see <a title="BNF:target-block: hepatic, renal and pregnancy opioids " href="3491.htm#_204134">notes above</a></p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">see <a title="BNF:target-block: hepatic, renal and pregnancy opioids " href="3491.htm#_204134">notes above</a></p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">see <a title="BNF:target-block: hepatic, renal and pregnancy opioids " href="3491.htm#_204134">notes above</a> and <a title="BNF:target-block: Pregnancy notes" href="213722.htm#_213813">section 4.10.3</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">present in low levels in breast milk—monitor
neonate for drowsiness, adequate weight gain, and developmental milestones</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see <a title="target-block: OPIOID ANALGESIC SIDE-EFFECTS" href="3491.htm#_200095">notes above</a>; can induce
mild withdrawal symptoms in patients dependent on opioids; also diarrhoea,
abdominal pain, anorexia, dyspepsia; vasodilatation; dyspnoea; paraesthesia,
asthenia, fatigue, agitation, anxiety; <i>less commonly</i> flatulence, taste disturbance, angina, hypertension, syncope, hypoxia,
wheezing, cough, restlessness, depersonalisation, dysarthria, impaired
memory, hypoaesthesia, tremor, influenza-like symptoms, pyrexia, rhinitis,
rigors, muscle cramp, myalgia, tinnitus, dry eye, and dry skin; <i>rarely</i> paralytic ileus, dysphagia, impaired concentration,
and psychosis; <i>very rarely</i> retching, hyperventilation,
hiccups, and muscle fasciculation; hepatic necrosis and hepatitis
also reported</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Moderate to severe pain, <span class="cU">by sublingual administration</span>, 200–400 micrograms every 6–8 hours; <span class="cAK">child</span> over 6 years, 16–25 kg, 100 micrograms every 6–8 hours; 25–37.5 kg,
100–200 micrograms every 6–8 hours; 37.5–50 kg, 200–300 micrograms
every 6–8 hours</p><p class="cS"><span class="cU">By intramuscular</span><i> or </i><span class="cU">slow
intravenous injection</span>, 300–600 micrograms every 6–8 hours; <span class="cAK">child</span> over 6 months 3–6 micrograms/kg every 6–8 hours
(max. 9 micrograms/kg)</p><p class="cR">Premedication, <span class="cU">by sublingual administration</span>, 400 micrograms</p><p class="cS"><span class="cU">By intramuscular injection</span>, 300 micrograms</p><p class="cR">Intra-operative analgesia, <span class="cU">by slow intravenous injection</span>, 300–450 micrograms</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="3513.htm#_3513" title="Temgesic®">Temgesic®</a></li><li><h1 class="title">Patches</h1><ul><li><a href="129413.htm#_129413" title="BuTrans®">BuTrans®</a></li><li class="jN" id="_106521" style="margin: 0 0 0 20px;"><h1 class="title">Transtec®<span> (<a href="appendix-112803-N.htm#m201">Napp</a>)</span> <a href="29424.htm#_120032" title="Schedule 3 Controlled Drug"><img class="cJ" src="images/cd3_l.png" alt="Schedule 3 Controlled Drug" /></a></h1><div class="cAY"><span class="cAB">Patches</span>, self-adhesive, skin-coloured, <span>buprenorphine</span>, ‘35’ patch (releasing 35 micrograms/hour
for 96 hours), net price 4 = £15.73; ‘52.5’ patch (releasing 52.5 micrograms/hour
for 96 hours), 4 = £23.61; ‘70’ patch (releasing 70 micrograms/hour
for 96 hours), 4 = £31.46. 
    Label:
    2<div class="cAQ"><div class="cAF"><h2>Dose</h2> <p class="cAF">moderate to severe chronic cancer pain and severe pain
unresponsive to non-opioid analgesics, <span class="cAK">adult</span> over 18 years, apply to dry, non-irritated, non-hairy skin on upper
torso, removing after no longer than 96 hours and siting replacement
patch on a different area (avoid same area for at least 6 days). Patients
who have not previously received strong opioid analgesic, initially,
one ‘35 micrograms/hour’ patch replaced after no longer than 96 hours;
patients who have received strong opioid analgesic, initial dose based
on previous 24-hour opioid requirement, consult product literature </p></div><div class="cAV"><h3>Dose adjustment</h3> <p class="cAX">When starting, analgesic effect
should <b>not</b> be evaluated until the system has been
worn for <b>24 hours</b> (to allow for gradual increase
in plasma-buprenorphine concentration)—if necessary, dose should be
adjusted at intervals of no longer than 96 hours using a patch of
the next strength <i>or</i> using 2 patches of the same
strength (applied at <i>same time</i> to avoid confusion).
Max. 2 patches can be used at any one time. For breakthrough pain,
consider 200–400 micrograms buprenorphine sublingually. <b>Important:</b> it may take approx. 30 hours for the plasma-buprenorphine concentration
to decrease by 50% after patch is removed</p></div><div class="cAV"><h3>Long duration of action</h3> <p class="cAX">In view of the long duration
of action, patients who have severe side-effects should be monitored
for up to 30 hours after removing patch</p></div></div></div></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="3491.htm">Previous: 4.7.2 Opioid analgesics</a> | <a class="top" href="106521.htm#">Top</a> | <a accesskey="]" href="3514.htm">Next: CODEINE PHOSPHATE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>